These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9252380)
21. Plasmin reduction by phosphoglycerate kinase is a thiol-independent process. Lay AJ; Jiang XM; Daly E; Sun L; Hogg PJ J Biol Chem; 2002 Mar; 277(11):9062-8. PubMed ID: 11782484 [TBL] [Abstract][Full Text] [Related]
22. Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients. Cao Y; Veitonmaki N; Keough K; Cheng H; Lee LS; Zurakowski D Int J Mol Med; 2000 May; 5(5):547-51. PubMed ID: 10762660 [TBL] [Abstract][Full Text] [Related]
23. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. Sharma MR; Rothman V; Tuszynski GP; Sharma MC Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891 [TBL] [Abstract][Full Text] [Related]
25. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells. Binda MM; Matar P; González AD; Rozados VR; Gervasoni SI; Scharovsky OG; Bonfil RD Int J Cancer; 2002 Jul; 100(1):14-21. PubMed ID: 12115581 [TBL] [Abstract][Full Text] [Related]
26. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387 [TBL] [Abstract][Full Text] [Related]
27. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Sharma MC; Sharma M Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793 [TBL] [Abstract][Full Text] [Related]
29. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. O'Reilly MS; Wiederschain D; Stetler-Stevenson WG; Folkman J; Moses MA J Biol Chem; 1999 Oct; 274(41):29568-71. PubMed ID: 10506224 [TBL] [Abstract][Full Text] [Related]
30. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. Morikawa W; Yamamoto K; Ishikawa S; Takemoto S; Ono M; Fukushi Ji; Naito S; Nozaki C; Iwanaga S; Kuwano M J Biol Chem; 2000 Dec; 275(49):38912-20. PubMed ID: 10986284 [TBL] [Abstract][Full Text] [Related]
32. Cell surface-dependent generation of angiostatin4.5. Wang H; Schultz R; Hong J; Cundiff DL; Jiang K; Soff GA Cancer Res; 2004 Jan; 64(1):162-8. PubMed ID: 14729620 [TBL] [Abstract][Full Text] [Related]
33. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. Redlitz A; Daum G; Sage EH J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071 [TBL] [Abstract][Full Text] [Related]
34. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Sack RA; Beaton AR; Sathe S Curr Eye Res; 1999 Mar; 18(3):186-93. PubMed ID: 10342373 [TBL] [Abstract][Full Text] [Related]
35. Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp. Lijnen HR; Van Hoef B; Ugwu F; Collen D; Roelants I Biochemistry; 2000 Jan; 39(2):479-88. PubMed ID: 10631010 [TBL] [Abstract][Full Text] [Related]
36. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). Majumdar M; Tarui T; Shi B; Akakura N; Ruf W; Takada Y J Biol Chem; 2004 Sep; 279(36):37528-34. PubMed ID: 15247268 [TBL] [Abstract][Full Text] [Related]
37. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system. Aisina RB; Mukhametova LI; Gulin DA; Levashov MY; Prisyazhnaya NV; Gershkovich KB; Varfolomeyev SD Biochemistry (Mosc); 2009 Oct; 74(10):1104-13. PubMed ID: 19916923 [TBL] [Abstract][Full Text] [Related]
39. Glutathione and thioredoxin systems contribute to recombinant monoclonal antibody interchain disulfide bond reduction during bioprocessing. Handlogten MW; Zhu M; Ahuja S Biotechnol Bioeng; 2017 Jul; 114(7):1469-1477. PubMed ID: 28262915 [TBL] [Abstract][Full Text] [Related]
40. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes. Hoffman R; Starkey S; Coad J J Invest Dermatol; 1998 Dec; 111(6):1140-4. PubMed ID: 9856830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]